---
title: "Two consecutive limit-up for APON: No undisclosed significant matters exist"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/271635971.md"
description: "36Kr learned that Apon Medical, which has seen a consecutive two-day trading suspension, disclosed a stock trading anomaly announcement stating that the company's recent operating conditions are normal, and there have been no significant changes in the internal and external operating environment. The company, its controlling shareholders, and actual controllers do not have any significant matters related to the company that should be disclosed but have not been disclosed, nor are there any significant matters in the planning stage"
datetime: "2026-01-06T10:16:45.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/271635971.md)
  - [en](https://longbridge.com/en/news/271635971.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/271635971.md)
---

# Two consecutive limit-up for APON: No undisclosed significant matters exist

36Kr learned that Apon Medical, which has seen a consecutive two-day trading limit increase, disclosed a stock trading anomaly announcement stating that the company's recent operating conditions are normal, and there have been no significant changes in the internal and external operating environment. The company, its controlling shareholders, and actual controllers do not have any significant matters related to the company that should be disclosed but have not been disclosed, nor are there any significant matters in the planning stage

### Related Stocks

- [300753.CN](https://longbridge.com/en/quote/300753.CN.md)

## Related News & Research

- [Comey eyes new 'anti-weaponization' fund: 'I'm guessing I'll be in line'](https://longbridge.com/en/news/286948735.md)
- [Scott Jennings voices concern over Trump's $1.7B DOJ fund](https://longbridge.com/en/news/286922300.md)
- [Trump faces record-low approval on inflation as retirees struggle](https://longbridge.com/en/news/286834439.md)
- [World is more vulnerable to pandemics despite Covid-19 lessons, warns WHO](https://longbridge.com/en/news/286895865.md)
- [Audemars Piguet is walking a fine line between cheapening its brand and riding a lucrative hype train](https://longbridge.com/en/news/286872823.md)